Update from the 4th World Congress on Theranostics

4th World Congress on Theranostics

Melbourne, November 2016

The theme of the most recent World Congress (a bi-annual meeting to highlight the developments in radio-peptide imaging and therapy) was PRRT for Neuroendocrine and prostate cancers. Through the organizing committee (from the Peter McCallum Cancer Institute and the Unicorn Foundation – a not-for profit charity for NETs in Australia) a series of lectures on the past, present and future of PRRT were presented as well as research papers on novel therapies and clinical trials. The patient voice was also represented. Through the Unicorn Foundation the talks have been put on You-Tube for everyone to access.

Dr Andrew Scarsbrook (Consultant in Nuclear Medicine and Radiology, Leeds Teaching Hospitals) has highlighted his pick of the bunch for the NETs community although the whole series of 19 talks can be found as indicated below.

Selected Talks from 4th Theranostics World Congress – Nov 2016 Melbourne 

PRRT Highlights

Theranostics in NET: Where have we been and where are we going ? –  Prof Rod Hicks, Peter MacCallum Cancer Centre https://www.youtube.com/watch?v=zjsh3DUyPX4

Where are we going with PRRT ? – Dr Grace Kong , Peter MacCallum Cancer Centre https://www.youtube.com/watch?v=7sYqkZpUc1A&index=4&list=PLrYQ1sbJT78tk3R6OWDCSGQ-_pjc5MzIH

Two Decades of THERANOSTICS in Neuroendocrine Tumors – Past, Present and Future of Peptide Receptor Radionuclide Therapy (PRRT) – Dr Harshad R Kulkarni, THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka https://www.youtube.com/watch?v=mfzpZWKTGis&list=PLrYQ1sbJT78sosaGKxFlrlLTtTTGzRfj2&index=8

NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy, Safety, QoL Results and Sub-group Analysis – Prof Jonathan Strosberg, Moffitt Cancer Center https://www.youtube.com/watch?v=n0Qhx7Ja_Sg&index=9&list=PLrYQ1sbJT78sosaGKxFlrlLTtTTGzRfj2

Clinical Perspective: The “difficult development situation”: how to approach and overcome challenges from a regulatory perspective – Hans-Georg Eichler, European Medicines Agency https://www.youtube.com/watch?v=4l0-3N1zCJI&index=10&list=PLrYQ1sbJT78sosaGKxFlrlLTtTTGzRfj2

The Cruel Wait for PRRT – Prof Paul Stephenson, The Unicorn Foundation https://www.youtube.com/watch?v=ZixBsdVr6dE&index=11&list=PLrYQ1sbJT78sosaGKxFlrlLTtTTGzRfj2

The challenges of waiting for RCTs vs treating patients now – Josh Mailman, NorCal CarciNET Community https://www.youtube.com/watch?v=BrSAotEb3tA&index=12&list=PLrYQ1sbJT78sosaGKxFlrlLTtTTGzRfj2

Where are we going with PET ? – Dr Michael Hofman, Peter MacCallum Cancer Centre https://www.youtube.com/watch?v=qHbTkffJeJU&index=2&list=PLrYQ1sbJT78tk3R6OWDCSGQ-_pjc5MzIH

Other talks available at: